Pharmaceutical Executive February 10, 2025
Mike Hollan

Biljana Naumovic discusses how a new study attempted to bring in patients from underserved communities.

Biljana Naumovic, president of US Oncology Solid Tumor at Johnson & Johnson, spoke with Pharmaceutical Executive about her work with Johnson & Johnson to spread awareness around the importance of early diagnosis for prostate cancer. According to her, this cancer is one of the leading causes of death in men and is often missed during the early stages due to a lack of proper testing.

Pharmaceutical Executive: Can you discuss the Blue Jacket Fashion Show?
Biljana Naumovic: We have been involved in the Blue Jacket Fashion Show now for almost a decade. It is part of our dedication to the prostate cancer community and is a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Interview / Q&A, Medical Devices, Survey / Study, Trends
Related Articles:
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Micro-X gets $16 million contract to develop mobile full-body CT
The transformation imperative: Igniting value creation in medtech
Aluminum, steel tariffs expected to impact medical devices
Neuralink competitor Paradromics secures investment from Saudi Arabia's Neom

Share This Article